Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-06 | New | $5,999,138 | $5,999,138 | Equity Only | 06b | SEC link |
| 2023-05-12 | New | $13,915,153 | $13,915,153 | Equity Only | 06b | SEC link |
| 2021-03-31 | New | $40,625,995 | $40,625,995 | Equity Only | 06b | SEC link |
| 2018-09-06 | New | $18,999,999 | $18,999,999 | Equity Only | 06b | SEC link |
| 2017-03-23 | Amended | $29,499,000 | $10,000,000 | Equity Only | 06b | SEC link |
| 2016-05-26 | Amended | $19,499,000 | $3,000,000 | Equity Only | 06b | SEC link |
| 2015-10-15 | New | $16,499,000 | $16,499,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Alice Bexon | Executive |
| Roberto De Ponti | Director |
| Carol Gallagher | Director |
| Steve Gillis | Director |
| Steven Gillis | Director |
| Alan Ginsberg | Director |
| Russ Hawkinson | Executive |
| Patrick Joseph Hojlo | Director |
| Wende Hutton | Director |
| Nathan Jorgensen | Director |
| Ted Koutouzis | Director |
| Bob Lechleider | Executive |
| Robert J. Lechleider | Executive |
| Sean A. Mc Carthy | Director |
| John Mc Kearn | Director |
| Andrew Perlman | Director |
| Kamal D. Puri | Executive |
| Christopher A. Russell | Executive |
| Chris Russell | Executive |
| Clifford J. Stocks | Director, Executive |
| Kristine Swiderek | Executive |
| Geeta Vemuri | Director |
| Daguang Wang | Director |